Manifestations oculaires de la maladie de Behçet

Shimizu, 1974, Behcet's syndrome – lists of clinical and epidemical statistics, Nippon Rinsho, 32, 2093

Mizushima, 1988, Revised diagnostic criteria for Behcet's disease in 1987, Ryumachi, 28, 66

International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078–80.

Azizlerli, 2003, Prevalence of Behcet's disease in Istanbul, Turkey, Int J Dermatol, 42, 803, 10.1046/j.1365-4362.2003.01893.x

Chamberlain, 1977, Behcet's syndrome in 32 patients in Yorkshire, Ann Rheum Dis, 36, 491, 10.1136/ard.36.6.491

Mahr, 2008, Population-based prevalence study of Behcet's disease: differences by ethnic origin and low variation by age at immigration, Arthritis Rheum, 58, 3951, 10.1002/art.24149

Wechsler, 2002, Manifestations neurologiques de la maladie de Behçet, Rev Neurol, 158, 926

Jaber, 2002, Prevalence of Behcet's disease in an Arab community in Israel, Ann Rheum Dis, 61, 365, 10.1136/ard.61.4.365

Sungur, 2009, Clinical and demographic evaluation of Behcet disease among different paediatric age groups, Br J Ophthalmol, 93, 83, 10.1136/bjo.2007.137141

Tugal-Tutkun, 2004, Uveitis in Behcet disease: an analysis of 880 patients, Am J Ophthalmol, 138, 373, 10.1016/j.ajo.2004.03.022

Kump, 2008, Behcet's disease: comparing 3 decades of treatment response at the National Eye Institute, Can J Ophthalmol, 43, 468, 10.3129/i08-080

Wechsler, 2000, Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet's disease, Ocul Immunol Inflamm, 8, 293, 10.1076/ocii.8.4.293.6453

Guex-Crosier, 1995, Sensitivity of laser flare photometry to monitor inflammation in uveitis of the posterior segment, Ophthalmology, 102, 613, 10.1016/S0161-6420(95)30976-1

Bodaghi, 2007, Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients, Br J Ophthalmol, 91, 335, 10.1136/bjo.2006.101550

Atmaca, 1996, A descriptive study on Behcet's disease, Acta Ophthalmol Scand, 74, 403, 10.1111/j.1600-0420.1996.tb00718.x

Jabs, 2005, Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop, Am J Ophthalmol, 140, 509, 10.1016/j.ajo.2005.03.057

Evereklioglu, 2005, Current concepts in the etiology and treatment of Behcet disease, Surv Ophthalmol, 50, 297, 10.1016/j.survophthal.2005.04.009

Yazici, 2007, Behcet's syndrome: disease manifestations, management, and advances in treatment, Nat Clin Pract Rheumatol, 3, 148, 10.1038/ncprheum0436

Mochizuki, 1991, A multicenter clinical open trial of FK 506 in refractory uveitis, including Behcet's disease, Transplant Proc, 23, 3343

Chung, 2008, Behcet's disease with uveitis in Taiwan, J Chin Med Assoc, 71, 509, 10.1016/S1726-4901(08)70159-X

Yazici, 1984, Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome, Ann Rheum Dis, 43, 783, 10.1136/ard.43.6.783

Benezra, 1999, Clinical aspects and diagnostic guidelines of ocular Behcet's disease, Dev Ophthalmol, 31, 109, 10.1159/000060760

Kural-Seyahi, 2003, The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center, Medicine, 82, 60, 10.1097/00005792-200301000-00006

Cochereau-Massin, 1992, Pronostic oculaire de la maladie de Behcet, J Fr Ophtalmol, 15, 343

Verity, 1999, Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives, Tissue Antigens, 54, 213, 10.1034/j.1399-0039.1999.540301.x

Narikawa, 1995, Streptococcus oralis previously identified as uncommon ‘Streptococcus sanguis’ in Behcet's disease, Arch Oral Biol, 40, 685, 10.1016/0003-9969(95)00042-N

Ahn, 2005, CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis, J Immunol, 175, 6133, 10.4049/jimmunol.175.9.6133

Hatemi, 2008, EULAR recommendations for the management of Behcet disease, Ann Rheum Dis, 67, 1656, 10.1136/ard.2007.080432

Mochizuki, 1997, Immunotherapy for Behcet's disease, Int Rev Immunol, 14, 49, 10.3109/08830189709116844

Benezra, 1986, Treatment and visual prognosis in Behcet's disease, Br J Ophthalmol, 70, 589, 10.1136/bjo.70.8.589

Yazici, 1990, A controlled trial of azathioprine in Behcet's syndrome, N Engl J Med, 322, 281, 10.1056/NEJM199002013220501

Ozyazgan, 1992, Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial, Br J Ophthalmol, 76, 241, 10.1136/bjo.76.4.241

Hamuryudan, 2002, Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study, Isr Med Assoc J, 4, 928

Hamuryudan, 1997, Azathioprine in Behcet's syndrome: effects on long-term prognosis, Arthritis Rheum, 40, 769, 10.1002/art.1780400425

Davatchi, 2003, High dose methotrexate for ocular lesions of Behcet's disease. Preliminary short-term results, Adv Exp Med Biol, 528, 579, 10.1007/0-306-48382-3_118

Bodaghi, 2005, Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors, Ann Rheum Dis, 64, 962, 10.1136/ard.2004.025882

Neri, 2008, Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil, Int Ophthalmol

Du, 1990, Intérêt des bolus de cyclophosphamide dans la maladie de Behçet, expérience de 17 cas, Presse Med, 19, 1355

Whitcup, 1994, Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease, Am J Ophthalmol, 118, 39, 10.1016/S0002-9394(14)72840-5

Benezra, 1988, Evaluation of conventional therapy versus cyclosporine A in Behcet's syndrome, Transplant Proc, 20, 136

Nussenblatt, 1985, Effectiveness of cyclosporin therapy for Behcet's disease, Arthritis Rheum, 28, 671, 10.1002/art.1780280611

Tabbara, 2008, Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behcet disease, Am J Ophthalmol, 146, 10.1016/j.ajo.2008.09.010

Ozdal, 2002, Long-term therapy with low dose cyclosporin A in ocular Behcet's disease, Doc Ophthalmol, 105, 301, 10.1023/A:1021227019915

Masuda, 1989, Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease, Lancet, 1, 1093, 10.1016/S0140-6736(89)92381-7

Sullu, 1998, Cyclosporin-A therapy in severe uveitis of Behcet's disease, Acta Ophthalmol Scand, 76, 96, 10.1034/j.1600-0420.1998.760118.x

Kotake, 1999, Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy, Ophthalmology, 106, 586, 10.1016/S0161-6420(99)90120-3

Sakane, 1995, A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behcet's disease and allied conditions, Ryumachi, 35, 802

Murphy, 2005, Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis, Arch Ophthalmol, 123, 634, 10.1001/archopht.123.5.634

Wechsler, 2002, Interférons et maladie de Behçet, Rev Med Interne, 23, 495s, 10.1016/S0248-8663(02)00665-3

Alpsoy, 2002, Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study, Arch Dermatol, 138, 467, 10.1001/archderm.138.4.467

Gueudry, 2008, Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behcet disease, Am J Ophthalmol, 146, 837, 10.1016/j.ajo.2008.08.038

Kotter, 2005, Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behcet's disease: focusing more on IFN, J Rheumatol, 32, 1633

Tugal-Tutkun, 2006, Results of interferon-alfa therapy in patients with Behcet uveitis, Graefes Arch Clin Exp Ophthalmol, 244, 1692, 10.1007/s00417-006-0346-y

Wechsler, 2004, Infliximab in refractory uveitis due to Behcet's disease, Clin Exp Rheumatol, 22, S14

Niccoli, 2007, Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study, Rheumatology (Oxford), 46, 1161, 10.1093/rheumatology/kem101

Tugal-Tutkun, 2005, Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease: an open-label trial, Arthritis Rheum, 52, 2478, 10.1002/art.21231

Tognon, 2007, Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects, Ann N Y Acad Sci, 1110, 474, 10.1196/annals.1423.050

Estrach, 2002, Behcet's syndrome: response to infliximab after failure of etanercept, Rheumatology, 41, 1213, 10.1093/rheumatology/41.10.1213-b

Tran, 1998, Effect of cataract surgery with intraocular lens implantation on inflammation in chronic uveitis: a longitudinal laser flare photometry study, Can J Ophthalmol, 33, 264

Chung, 1990, Intraocular lens implantation following extracapsular cataract extraction in uveitis, Ophthalmic Surg, 21, 272